A Phase I/II, Open-Label, Escalating Dose, "Optimal Two-Stage", Study of TNFalpha-Kinoid (TNF- K) Immunization in Crohn's Disease Patients

Trial Profile

A Phase I/II, Open-Label, Escalating Dose, "Optimal Two-Stage", Study of TNFalpha-Kinoid (TNF- K) Immunization in Crohn's Disease Patients

Completed
Phase of Trial: Phase I/II

Latest Information Update: 07 Jun 2011

At a glance

  • Drugs Tumour necrosis factor-alpha kinoid (Primary)
  • Indications Crohn's disease
  • Focus Adverse reactions
  • Most Recent Events

    • 02 May 2011 Results will be presented at Digestive Disease Week, according to a Neovacs media release.
    • 12 Jan 2011 Results were reported in an oral presentation at the 2011 European Crohn's and Colitis Organisation (ECCO).
    • 08 Dec 2010 Results were reported in a Neovacs media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top